PGC-1α promoter methylation in Parkinson's disease

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Su, Xiaomin ^a   Chu, Yaping ^b   Kordower, Jeffrey H ^b   Li, Bin ^a   Cao, Hong ^a   Huang, Liang ^a   Nishida, Maki ^c   Song, Lei ^c   Wang, Difei ^c   Federoff, Howard J ^a,d  

^a GEORGETOWN UNIVERSITY   (United States)

^b RUSH UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PPARGC1A PROTEIN, HUMAN; PPARGC1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EMBRYO; ENDOPLASMIC RETICULUM STRESS; EPIGENETICS; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; GLIA CELL; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; MICROGLIA; MOLECULAR PATHOLOGY; MOUSE; MOUSE MUTANT; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARKINSON DISEASE; PGC 1ALPHA GENE; PROMOTER REGION; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; UPREGULATION; VERY ELDERLY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANIMALS; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; PALMITIC ACID; PARKINSON DISEASE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; PROMOTER REGIONS, GENETIC; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS;

EID: 84943339728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134087     Document Type: Article

References (61)

1. Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, et al. PGC-1 α, a potential therapeutic target for early intervention in Parkinson's disease. SciTransl Med. 2010;2(52):52ra73. Epub 2010/10/12. doi: 10.1126/scitranslmed.3001059 PMID: 20926834; PubMed Central PMCID: PMC3129986.
2. Eschbach J, von Einem B, Muller K, Bayer H, Scheffold A, Morrison BE, et al. Mutual exacerbation of peroxisome proliferator-activated receptor gamma coactivator 1a deregulation and α-synuclein oligomerization. Annals of neurology. 2015;77(1):15-32. doi: 10.1002/ana.24294 PMID: 25363075; PubMed Central PMCID: PMC4293280.
3. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocrine reviews. 2006;27(7):728-35. doi: 10.1210/er. 2006-0037 PMID: 17018837.
4. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell metabolism. 2005;1(6):361-70. doi: 10.1016/j.cmet.2005.05.004 PMID: 16054085.
5. Soyal S, Krempler F, Oberkofler H, Patsch W. PGC-1 α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia. 2006;49(7):1477-88. doi: 10.1007/s00125-006-0268-6 PMID: 16752166.
6. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D. Transcriptional repression of PGC-1 a by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006;127(1):59-69. Epub 2006/10/05. doi: 10.1016/j.cell.2006.09.015 PMID: 17018277.
7. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006;127(2):397-408. Epub 2006/10/24. doi: 10.1016/j.cell.2006.09.024 PMID: 17055439.
8. Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1 a in Huntington's disease neurodegeneration. Cell metabolism. 2006;4(5):349-62. Epub 2006/10/24. doi: 10.1016/j.cmet. 2006.10.004 PMID: 17055784.
9. Parker WD Jr., Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Annals of neurology. 1989;26(6):719-23. Epub 1989/12/01. doi: 10.1002/ana. 410260606 PMID: 2557792.
10. Janetzky B, Hauck S, Youdim MB, Riederer P, Jellinger K, Pantucek F, et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett. 1994;169(1-2):126-8. Epub 1994/03/14. PMID: 8047266.
11. Burdge GC, Lillycrop KA. Fatty acids and epigenetics. CurrOpin Clin NutrMetab Care. 2014;17(2):156-61. Epub 2013/12/11. doi: 10.1097/MCO.0000000000000023 PMID: 24322369.
12. Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Annals of neurology. 1996;39(1):89-94. Epub 1996/01/01. doi: 10.1002/ana.410390113 PMID: 8572672.
13. Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A. Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol. 2003;157(11):1007-14. Epub 2003/06/05. PMID: 12777364.
14. Morris JK, Bomhoff GL, Stanford JA, Geiger PC. Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol. 2010;299(4):R1082-90. Epub 2010/08/13. doi: 10.1152/ajpregu.00449.2010 PMID: 20702796; PubMed Central PMCID: PMC2957375.
15. Lu M, Hu G. Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies. Clin Exp Pharmacol Physiol. 2012;39(6):577-85. Epub 2011/12/01. doi: 10.1111/j. 1440-1681.2011.05650.x PMID: 22126374.
16. Santiago JA, Potashkin JA. Shared dysregulated pathways lead to Parkinson's disease and diabetes. Trends Mol Med. 2013;19(3):176-86. Epub 2013/02/05. doi: 10.1016/j.molmed.2013.01.002 PMID: 23375873.
17. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care. 2007;30(4):842-7. Epub 2007/01/26. doi: 10.2337/dc06-2011 PMID: 17251276.
18. Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L, et al. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension. 2011;57(6):1094-100. Epub 2011/05/04. doi: 10.1161/HYPERTENSIONAHA.111.171249 PMID: 21536985.
19. Jafari S, Etminan M, Aminzadeh F, Samii A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013;28(9):1222-9. Epub 2013/04/24. doi: 10.1002/mds. 25458 PMID: 23609436.
20. Homayoun P, Rodriguez de Turco EB, Parkins NE, Lane DC, Soblosky J, Carey ME, et al. Delayed phospholipid degradation in rat brain after traumatic brain injury. J Neurochem. 1997;69(1):199-205. Epub 1997/07/01. PMID: 9202311.
21. Nicolai E, Cuocolo A, Acampa W, Varrone A, Pace L, Salvatore M. Exercise-test Tc-99mtetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection. J Nucl Cardiol. 1999;6(3):270-7. Epub 1999/06/29. PMID: 10385182.
22. Karmi A, Iozzo P, Viljanen A, Hirvonen J, Fielding BA, Virtanen K, et al. Increased brain fatty acid uptake in metabolic syndrome. Diabetes. 2010;59(9):2171-7. Epub 2010/06/23. doi: 10.2337/db09-0138 PMID: 20566663; PubMed Central PMCID: PMC2927939.
23. Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, et al. Behavioral and neurochemical effects of wild-type and mutated human α-synuclein in transgenic mice. Exp Neurol. 2002/05/16 ed2002. p. 35-48.
24. Grunau C, Schattevoy R, Mache N, Rosenthal A. MethTools-a toolbox to visualize and analyze DNA methylation data. Nucleic Acids Res. 2000;28(5):1053-8. Epub 2000/02/10. PMID: 10666443; PubMed Central PMCID: PMC102603.
25. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80. doi: 10.1186/gb-2004-5-10-r80 PMID: 15461798; PubMed Central PMCID: PMC545600.
26. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-64. doi: 10.1093/biostatistics/4.2.249 PMID: 12925520.
27. Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, et al. DNAmethylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One. 2007;2(9):e895. Epub 2007/09/20. doi: 10.1371/journal.pone.0000895 PMID: 17878930; PubMed Central PMCID: PMC1964879.
28. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. Intra-individual change overtime in DNA methylation with familial clustering. JAMA. 2008;299(24):2877-83. Epub 2008/06/26. doi: 10.1001/jama.299.24.2877 PMID: 18577732; PubMed Central PMCID: PMC2581898.
29. Outeiro TF, Lindquist S. Yeast cells provide insight into osynuclein biology and pathobiology. Science. 2003;302(5651):1772-5. Epub 2003/12/06. doi: 10.1126/science.1090439 PMID: 14657500; PubMed Central PMCID: PMC1780172.
30. Salvado L, Coll T, Gomez-Foix AM, Salmeron E, Barroso E, Palomer X, et al. Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia. 2013;56(6):1372-82. doi: 10.1007/s00125-013-2867-3 PMID: 23460021.
31. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470(7334):359-65. doi: 10.1038/nature09787 PMID: 21307849; PubMed Central PMCID: PMC3741661.
32. Mudo G, Makela J, Di Liberto V, Tselykh TV, Olivieri M, Piepponen P, et al. Transgenic expression and activation of PGC-1 a protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cellular and molecular life sciences: CMLS. 2012;69(7):1153-65. Epub 2011/10/11. doi: 10.1007/s00018-011-0850-z PMID: 21984601.
33. Sczelecki S, Besse-Patin A, Abboud A, Kleiner S, Laznik-Bogoslavski D, Wrann CD, et al. Loss of Pgc-1a expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation. American journal of physiology Endocrinology and metabolism. 2014;306(2):E157-67. Epub 2013/11/28. doi: 10.1152/ajpendo.00578.2013 PMID: 24280126.
34. Nijland PG, Witte ME, van Het Hof B, van der Pol S, Bauer J, Lassmann H, et al. Astroglial PGC-1a increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis. Acta neuropathologica communications. 2014;2(1):170. doi: 10.1186/s40478-014-0170-2 PMID: 25492529; PubMed Central PMCID: PMC4268800.
35. Bjorkqvist M, Wild EJ, Tabrizi SJ. Harnessing immune alterations in neurodegenerative diseases. Neuron. 2009;64(1):21-4. doi: 10.1016/j.neuron. 2009.09.034 PMID: 19840543.
36. Xie W, Barr CL, Kim A, Yue F, Lee AY, Eubanks J, et al. Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell. 2012;148(4):816-31. Epub 2012/02/22. doi: 10.1016/j.cell.2011.12.035 PMID: 22341451; PubMed Central PMCID: PMC3343639.
37. Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, et al. Global epigenomic reconfiguration during mammalian brain development. Science. 2013;341(6146):1237905. Epub 2013/07/06. doi: 10.1126/science.1237905 PMID: 23828890; PubMed Central PMCID: PMC3785061.
38. Guo JU, Su Y, Shin JH, Shin J, Li H, Xie B, et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci. 2014;17(2):215-22. Epub 2013/12/24. doi: 10.1038/nn. 3607 PMID: 24362762.
39. Varley KE, Gertz J, Bowling KM, Parker SL, Reddy TE, Pauli-Behn F, et al. Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 2013;23(3):555-67. Epub 2013/01/18. doi: 10.1101/gr.147942.112 PMID: 23325432; PubMed Central PMCID: PMC3589544.
40. Walsh CP, Bestor TH. Cytosine methylation and mammalian development. Genes Dev. 1999;13(1):26-34. Epub 1999/01/14. PMID: 9887097; PubMed Central PMCID: PMC316374.
41. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005;2 Suppl 1:S4-11. Epub 2005/12/13. doi: 10.1038/ncponc0354 PMID: 16341240.
42. Hermann A, Goyal R, Jeltsch A. The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J Biol Chem. 2004;279(46):48350-9. Epub 2004/09/02. doi: 10.1074/jbc. M403427200 PMID: 15339928.
43. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci. 2010;13(4):423-30. Epub 2010/03/17. doi: 10.1038/nn. 2514 PMID: 20228804; PubMed Central PMCID: PMC3060772.
44. Feng J, Chang H, Li E, Fan G. Dynamic expression of de novo DNAmethyltransferases Dnmt3aand Dnmt3b in the central nervous system. J Neurosci Res. 2005;79(6):734-46. Epub 2005/01/27. doi: 10. 1002/jnr.20404 PMID: 15672446.
45. Chestnut BA, Chang Q, Price A, Lesuisse C, Wong M, Martin LJ. Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci. 2011;31(46):16619-36. Epub 2011/11/18. doi: 10. 1523/JNEUROSCI.1639-11.2011 PMID: 22090490; PubMed Central PMCID: PMC3238138.
46. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, et al. Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibres. Nature. 2002;418(6899):797-801. Epub 2002/08/16. doi: 10. 1038/nature00904 PMID: 12181572.
47. Wenz T, Diaz F, Spiegelman BM, Moraes CT. Activation of the PPAR/PGC-1 α pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell metabolism. 2008;8(3):249-56. Epub 2008/09/03. doi: 10.1016/j.cmet.2008.07.006 PMID: 18762025; PubMed Central PMCID: PMC2613643.
48. Li L, Pan R, Li R, Niemann B, Aurich AC, Chen Y, et al. Mitochondrial biogenesis and peroxisome proliferator-activated receptor-gamma coactivator-1 a (PGC-1 a) deacetylation by physical activity: intact adipocytokine signaling is required. Diabetes. 2011;60(1):157-67. doi: 10.2337/db10-0331 PMID: 20929977; PubMed Central PMCID: PMC3012167.
49. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999;98(1):115-24. Epub 1999/07/21. doi: 10.1016/S0092-8674 (00) 80611-X PMID: 10412986.
50. Eisele PS, Salatino S, Sobek J, Hottiger MO, Handschin C. The peroxisome proliferator-activated receptor gamma coactivator 1 α/beta (PGC-1) coactivators repress the transcriptional activity of NF-kappaB in skeletal muscle cells. J BiolChem. 2013;288(4):2246-60. Epub 2012/12/12. doi: 10.1074/jbc. M112.375253 PMID: 23223635; PubMed Central PMCID: PMC3554897.
51. Valle I, Alvarez-Barrientos A, Arza E, Lamas S, Monsalve M. PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res. 2005;66(3):562-73. Epub 2005/05/26. doi: 10.1016/j.cardiores.2005.01.026 PMID: 15914121.
52. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, et al. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease. Cell. 2011;144(5):689-702. doi: 10.1016/j. cell.2011.02.010 PMID: 21376232; PubMed Central PMCID: PMC3063894.
53. Canto C, Auwerx J. PGC-1α, SIRT1 and AMPK, an energy sensing networkthat controls energy expenditure. CurrOpin Lipidol. 2009;20(2):98-105. Epub 2009/03/12. doi: 10.1097/MOL 0b013e328328d0a4 PMID: 19276888; PubMed Central PMCID: PMC3627054.
54. Wan Z, Root-McCaig J, Castellani L, Kemp BE, Steinberg GR, Wright DC. Evidence for the role of AMPK in regulating PGC-1 a expression and mitochondrial proteins in mouse epididymal adipose tissue. Obesity (Silver Spring). 2014;22(3):730-8. Epub 2013/08/22. doi: 10.1002/oby.20605 PMID: 23963743.
55. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39(6):889-909. PMID: 12971891.
56. Hsiao YH, Lin CI, Liao H, Chen YH, Lin SH. Palmitic acid-induced neuron cell cycle G2/M arrest and endoplasmic reticular stress through protein palmitoylation in SH-SY5Y human neuroblastoma cells. International journal of molecular sciences. 2014;15(11):20876-99. doi: 10.3390/ijms151120876 PMID: 25402647; PubMed Central PMCID: PMC4264201.
57. Baldwin AC, Green CD, Olson LK, Moxley MA, Corbett JA. A role for aberrant protein palmitoylation in FFA-induced ER stress and beta-cell death. American journal of physiology Endocrinology and metabolism. 2012;302(11):E1390-8. doi: 10.1152/ajpendo.00519.2011 PMID: 22436701; PubMed Central PMCID: PMC3378068.
58. Bartoszewski R, Rab A, Twitty G, Stevenson L, Fortenberry J, Piotrowski A, et al. The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response. J Biol Chem. 2008;283(18):12154-65. doi: 10.1074/jbc. M707610200 PMID: 18319256.
59. Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, Sonenberg N, et al. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol. 2004;24(23):10161-8. doi: 10.1128/MCB.24.23.10161-10168.2004 PMID: 15542827; PubMed Central PMCID: PMC529034.
60. Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. Autocrine tumor necrosis factorα links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1α-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol Cell Biol. 2006;26(8):3071-84. doi: 10.1128/MCB.26.8.3071-3084.2006 PMID: 16581782; PubMed Central PMCID: PMC1446932.
61. Barres R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, et al. Non-CpG methylationofthe PGC-1αpromoterthrough DNMT3B controls mitochondrial density. Cell metabolism. 2009;10(3):189-98. Epub 2009/09/03. doi: 10.1016/j.cmet.2009.07.011 PMID: 19723495.